Mylan launches Indian operations

Drug maker to focus on HIV/AIDS drugs

PITTSBURGH — Generic drug maker Mylan has begun commercial operations in India, focusing on drugs to treat HIV and AIDS, the company said Monday.

The company is launching 18 antiretroviral drugs for HIV/AIDS in India, which has the world's third-largest population of people with the disease, according to the National AIDS Control Organization.

"Mylan's mission is to provide the world's 7 billion people with access to high-quality medicine," Mylan CEO Heather Bresch said. "Through the initial launch in India of a broad and innovative ARV portfolio, we are taking another significant stride towards meeting that goal."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

Login or Register to post a comment.